GH Research PLC — Cash Flow (NASDAQ:GHRS) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 15.28 M26.2 M33.34 M42.28 M — Cash from investing activities -104 K84.69 M54.1 M65.14 M — Cash from financing activities 286.45 M0204 K304 K — Free cash flow 15.28 M26.2 M33.34 M42.28 M —

Nachrichten

RBC Capital erhöht Kursziel für GH Research auf 40 US-Dollar

GH Research stock price target raised to $40 from $33 at RBC Capital

Eli Lilly and Regencell among market cap stock movers on Wednesday

Needham hebt Kursziel für GH Research deutlich auf 29 US-Dollar an

GH Research stock price target raised to $29 from $19 at Needham

GH Research: Aktie springt nach Aufhebung des FDA-Genehmigungsstopps – Canaccord erhöht Kursziel

GH Research stock jumps as Canaccord raises price target on FDA hold lift

GH Research: FDA hebt "Clinical Hold" für Medikamentenkandidaten auf – Aktie springt an

GH Research stock rises as FDA lifts clinical hold on GH001

Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug

Tesla, Chevron among market cap stock movers on Monday

TD Cowen bestätigt Kaufempfehlung für GH Research